Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN116239623B reveals low-catalyst borate ester synthesis enabling high-purity pharmaceutical intermediate manufacturing with significant supply chain cost optimization.
Patent CN114751883B reveals a Pd-catalyzed carbonylation route. Delivers cost-effective, scalable production for high-purity pharmaceutical intermediates.
Patent CN114195711B reveals a novel Pd-catalyzed carbonylation route for quinoline-4(1H)-ones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN114195726B reveals a CuCl-catalyzed route for high-purity arylamine compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid catalysis. Offers high ee, mild conditions, and scalable production for pharmaceutical applications.
Novel palladium-catalyzed carbonylation method for indole and benzoxazine compounds. Offers scalable production and cost efficiency for pharmaceutical supply chains.
Novel sulfur-mediated method for high-purity triazole intermediates. Cost-effective, metal-free process ensures supply chain stability for pharma manufacturing.
Patent CN114195711B reveals efficient Pd-catalyzed carbonylation. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113683595B reveals sulfur-promoted synthesis for high-purity pharmaceutical intermediates. Offers cost reduction and scalable supply chain solutions for global buyers.
Novel iron catalyzed method for cyanomethyl carboxylate synthesis offers green chemistry advantages and supply chain stability for pharmaceutical intermediate manufacturing processes.
Patent CN112125856A reveals a safe palladium-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost-effective manufacturing solutions.
Novel one-step synthesis of benzofuran-3-carboxamides using Pd-catalyzed carbonylation. Offers high efficiency and substrate compatibility for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis for high-purity anticancer intermediates. Cost-effective scale-up and reliable supply chain solutions for global pharmaceutical manufacturing partners.
Patent CN112239456B details a safe Pd-catalyzed carbonylation route for 2,3-dihydroquinolone intermediates, offering significant cost reduction in API manufacturing.
Patent CN115353511A details a safe, multi-component synthesis of indolinone-imidazole derivatives using in-situ CO generation, offering significant cost reduction in API manufacturing.
Patent CN109678840B reveals normal pressure hydrogenation for high-purity pomalidomide. Reduces equipment costs and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN115286635A details a metal-free asymmetric synthesis of chiral pyrazolones with high ee. Offers cost-effective manufacturing for pharmaceutical intermediates.
Patent CN102924362B reveals green synthesis for Gliclazide intermediate. Offers high purity, reduced waste, and scalable surfactant systems for reliable supply chains.
Patent CN104086456A details a green Suzuki coupling method for sartanbiphenyl, offering cost reduction in API intermediate manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed synthesis offers high enantioselectivity. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.